Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

ClinicalTrials.gov ID: NCT02749825

Public ClinicalTrials.gov record NCT02749825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Clinical Investigation of Trelstar Versus Continued Therapy in Patients Receiving Lupron or Zoladex for Advanced Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study looks at Testosterone levels in patients receiving Trelstar versus those receiving Lupron or Zoladex. These drugs have been approved for treatment of Prostate Cancer by the FDA.

Study identification

NCT ID
NCT02749825
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pharmatech
Industry
Enrollment
41 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2002 (Type not available)
Primary completion
May 2006 (Actual)
Completion
Jul 2006 (Actual)
Last update posted
Apr 25, 2016

2002 – 2006

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Arizona Urologic Specialists Tucson Arizona 85712-5803 —
Heritage Physician Group - Urology Department Hot Springs Arkansas 71913 —
California Oncology of the Central Valley Fresno California 93710 —
San Bernardino Urological Associates Medical Group San Bernardino California 92404 —
UroSearch Ocala Florida 34470 —
Scott A Slavis, MD, PC Las Vegas Nevada 89109 —
Shaukat M Qureshi, MD Pennsville New Jersey 08070 —
Brooklyn Heights Urology Associates Brooklyn New York 11201 —
Jazrawi-Atallah, P.C. Brooklyn New York 11201 —
Albemarle Urology Clinic, PA Albemarle North Carolina 28001 —
Raj P. Chopra MD, PC Bloomsburg Pennsylvania 17815 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02749825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02749825 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →